What is the current Short Bowel Syndrome Market size?

The Short Bowel Syndrome Market is projected to register a CAGR of 12.10% during the forecast period (2024-2029) Read More

Who are the key players in Short Bowel Syndrome Market?

TAKEDA Inc, OxThera, VectivBio AG, Ardelyx and Nutricia are the major companies operating in the Short Bowel Syndrome Market. Read More

Which is the fastest growing region in Short Bowel Syndrome Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Short Bowel Syndrome Market?

In 2024, the North America accounts for the largest market share in Short Bowel Syndrome Market. Read More

What years does this Short Bowel Syndrome Market cover?

The report covers the Short Bowel Syndrome Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Short Bowel Syndrome Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Short Bowel Syndrome Market Share

Market Share of Short Bowel Syndrome Industry

The short bowel syndrome market is moderately competitive and consists of several prominent industry players. Prominent players in the market are making partnerships and acquiring the products in the market, and other companies are expanding their market position globally. Some of the companies in the market include TAKEDA Inc, VectivBio AG, OxThera Inc, Nutricia, Ardelyx, and Zealand Pharma, among others.

Short Bowel Syndrome Market Leaders

TAKEDA Inc
OxThera
VectivBio AG
Ardelyx
Nutricia

*Disclaimer: Major Players sorted in no particular order

Short Bowel Syndrome Market Concentration